Index Catalog // MEDSpace

Start Over

Filtering by: Contributor Li, Fang Study Program Molecular Medicine Study Program (MolMed)

Description/Abstract:: Background BRAF mutations are common in melanoma, with more than 50% harboring activating BRAF mutations. Though BRAF inhibitors are highly efficacious for nearly half of patients with this BRAF-mutant melanoma, many developing secondary resistance...
Date:: August 1-2, 2024

Limit your search